American Century Companies’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.01M | Buy |
89,625
+1,689
| +2% | +$19K | ﹤0.01% | 2289 |
|
2025
Q1 | $887K | Buy |
87,936
+120
| +0.1% | +$1.21K | ﹤0.01% | 2289 |
|
2024
Q4 | $1.04M | Buy |
87,816
+441
| +0.5% | +$5.22K | ﹤0.01% | 2246 |
|
2024
Q3 | $1.01M | Buy |
87,375
+5,953
| +7% | +$68.7K | ﹤0.01% | 2230 |
|
2024
Q2 | $861K | Buy |
81,422
+17,074
| +27% | +$180K | ﹤0.01% | 2230 |
|
2024
Q1 | $678K | Buy |
64,348
+9,856
| +18% | +$104K | ﹤0.01% | 2311 |
|
2023
Q4 | $612K | Buy |
54,492
+569
| +1% | +$6.39K | ﹤0.01% | 2287 |
|
2023
Q3 | $630K | Buy |
53,923
+1,426
| +3% | +$16.7K | ﹤0.01% | 2183 |
|
2023
Q2 | $529K | Sell |
52,497
-382
| -0.7% | -$3.85K | ﹤0.01% | 2198 |
|
2023
Q1 | $387K | Sell |
52,879
-1,311
| -2% | -$9.58K | ﹤0.01% | 2211 |
|
2022
Q4 | $433K | Buy |
54,190
+25,838
| +91% | +$206K | ﹤0.01% | 2095 |
|
2022
Q3 | $91K | Buy |
+28,352
| New | +$91K | ﹤0.01% | 2347 |
|